DANCR has emerged as a pivotal regulator of drug resistance in NSCLC, and Nicolescu et al. reported a notable increase in DANCR expression in gefitinib-resistant NSCLC cell lines [38]. This evidence concerns the gene DANCR and non-small cell lung carcinoma.